Evidence map›Paper›PMID 42231677›Full record

ArticleRenal failure2026

Clinical impact of an EHR-integrated hyperkalemia management system: a real-world study of 10,934 episodes.

Guangna Lyu, Fang Zhang, Xiuzhao Fan, Rongshan Li, Xiaoshuang Zhou

Abstract read
In one paragraph

Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guangna LyuDepartment of Nephrology, Shanxi Provincial People's Hospital, Taiyuan, China.
Fang ZhangBig Data Center of Kidney Disease, Shanxi Provincial People's Hospital, Taiyuan, China.
Xiuzhao FanBig Data Center of Kidney Disease, Shanxi Provincial People's Hospital, Taiyuan, China.
Rongshan LiDepartment of Nephrology, Shanxi Provincial People's Hospital, Taiyuan, China.
Xiaoshuang ZhouDepartment of Nephrology, Shanxi Provincial People's Hospital, Taiyuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective study analyzed 10,934 hyperkalemia episodes to compare outcomes between the hyperkalemia routine group and the hyperkalemia standardized group, the latter managed with a strategy supported by the 'Serum Potassium Management Center System' in a real-world implementation setting. The study compared process and outcome metrics between this system-level intervention cohort and the routine care cohort. The hyperkalemia standardized group exhibited significantly higher rates of diagnosis (19.00% vs. 15.43%), treatment (85.23% vs. 58.29%), and review (89.41% vs. 60.86%) (all This trial was registered with the Chinese Clinical Trial Registry (ChiCTR) ChiCTR2600116550 on January 12, 2026.

Indexed as

Electronic Health RecordsHyperkalemiaRenal Insufficiency, ChronicAgedFemaleHeart FailureHospital CostsHospitalizationHumansLength of StayMaleMiddle AgedPotassiumRetrospective StudiesPotassiumdiagnosis ratedisease burdenHyperkalemiareview ratestandardized managementtreatment rate

Identifiers

PMID42231677
PMCPMC13235244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.